XML 56 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share-based compensation plans (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Activity related to restricted stock units
The activity related to RSUs for the year ended December 31, 2023 is as follows:
NonvestedVested
Total
Average Grant
Date Fair
Value Per Share
Outstanding, December 31, 2022462,395 73,309 535,704 $53.23 
   Granted325,771 — 325,771 $56.87 
   Vested(172,786)172,786 — 
   Converted(179,198)(179,198)$54.12 
   Cancelled(24,148)— (24,148)$55.79 
   Dividend equivalents2,213 1,918 4,131 $56.97 
Outstanding, December 31, 2023593,445 68,815 662,260 $54.71 
Activity related to performance contingent restricted stock units
The activity related to PCSUs for the year ended December 31, 2023 is as follows:
NonvestedVestedTotalAverage Grant Date Fair Value per Share
Outstanding, December 31, 2022599,382 302,400 901,782 $52.81
   Granted205,178 — 205,178 $55.04
   Performance adjustments(129,224)— (129,224)$55.04
   Vested(225,530)225,530 — 
   Converted— (291,818)(291,818)$51.68
   Cancelled(31,403)— (31,403)$54.08
   Dividend equivalents— 380 380 $56.99
Outstanding, December 31, 2023418,403 236,492 654,895 $53.51
Company's SARs The activity related to the Company’s SARs for the year ended December 31, 2023 is as follows: 
NonvestedVestedTotal
Weighted-
average
Exercise
Price
Outstanding, December 31, 2022— 764,806 764,806 $54.98 
   Vested— — — 
   Granted— — — $— 
   Exercised— (26,671)(26,671)$49.96 
   Forfeited/Expired— (8,620)(8,620)$— 
Outstanding, December 31, 2023— 729,515 729,515 $55.13 
Exercisable, December 31, 2023— 729,515 729,515 $55.13 
Schedule of other share-based compensation, activity
The activity related to deferred compensation for equity award units granted to both employees and non-employee directors combined is as follows:
Total
Outstanding, December 31, 2022287,015 
   Deferred36,254 
   Converted(8,406)
   Dividend equivalents9,739 
Outstanding, December 31, 2023324,602